Cargando…
Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643575/ https://www.ncbi.nlm.nih.gov/pubmed/25862556 http://dx.doi.org/10.1007/s10840-015-0001-9 |
| _version_ | 1782400539833663488 |
|---|---|
| author | Ezekowitz, Michael D. Ellenbogen, Kenneth A. DiMarco, John P. Kaszala, Karoly Boddy, Alexander Geba, Gregory P. Koren, Andrew |
| author_facet | Ezekowitz, Michael D. Ellenbogen, Kenneth A. DiMarco, John P. Kaszala, Karoly Boddy, Alexander Geba, Gregory P. Koren, Andrew |
| author_sort | Ezekowitz, Michael D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4643575 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46435752015-11-19 Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers Ezekowitz, Michael D. Ellenbogen, Kenneth A. DiMarco, John P. Kaszala, Karoly Boddy, Alexander Geba, Gregory P. Koren, Andrew J Interv Card Electrophysiol Erratum Springer US 2015-04-11 2015 /pmc/articles/PMC4643575/ /pubmed/25862556 http://dx.doi.org/10.1007/s10840-015-0001-9 Text en © Springer Science+Business Media New York 2015 |
| spellingShingle | Erratum Ezekowitz, Michael D. Ellenbogen, Kenneth A. DiMarco, John P. Kaszala, Karoly Boddy, Alexander Geba, Gregory P. Koren, Andrew Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers |
| title | Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers |
| title_full | Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers |
| title_fullStr | Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers |
| title_full_unstemmed | Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers |
| title_short | Erratum to: A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers |
| title_sort | erratum to: a placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643575/ https://www.ncbi.nlm.nih.gov/pubmed/25862556 http://dx.doi.org/10.1007/s10840-015-0001-9 |
| work_keys_str_mv | AT ezekowitzmichaeld erratumtoaplacebocontrolleddoubleblindrandomizedmulticenterstudytoassesstheeffectsofdronedarone400mgtwicedailyfor12weeksonatrialfibrillationburdeninsubjectswithpermanentpacemakers AT ellenbogenkennetha erratumtoaplacebocontrolleddoubleblindrandomizedmulticenterstudytoassesstheeffectsofdronedarone400mgtwicedailyfor12weeksonatrialfibrillationburdeninsubjectswithpermanentpacemakers AT dimarcojohnp erratumtoaplacebocontrolleddoubleblindrandomizedmulticenterstudytoassesstheeffectsofdronedarone400mgtwicedailyfor12weeksonatrialfibrillationburdeninsubjectswithpermanentpacemakers AT kaszalakaroly erratumtoaplacebocontrolleddoubleblindrandomizedmulticenterstudytoassesstheeffectsofdronedarone400mgtwicedailyfor12weeksonatrialfibrillationburdeninsubjectswithpermanentpacemakers AT boddyalexander erratumtoaplacebocontrolleddoubleblindrandomizedmulticenterstudytoassesstheeffectsofdronedarone400mgtwicedailyfor12weeksonatrialfibrillationburdeninsubjectswithpermanentpacemakers AT gebagregoryp erratumtoaplacebocontrolleddoubleblindrandomizedmulticenterstudytoassesstheeffectsofdronedarone400mgtwicedailyfor12weeksonatrialfibrillationburdeninsubjectswithpermanentpacemakers AT korenandrew erratumtoaplacebocontrolleddoubleblindrandomizedmulticenterstudytoassesstheeffectsofdronedarone400mgtwicedailyfor12weeksonatrialfibrillationburdeninsubjectswithpermanentpacemakers |